Iron-containing composition and method for treatment of cancer
US5246726A · kind A · utility
17Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 1992 |
| Grant date | Sep 21, 1993 |
| Priority date | — |
| Expiry date | Apr 21, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutically acceptable compositions of one or more n-6 or n-3 essential fatty acids, particularly gamma-linolenic acid, dihomo-gamma-linolenic acid, or eicosapentaenoic acid, and assimilable iron compounds, in dosage unit form optionally with a diluent or carrier, said acids being present as such or as derivatives convertible in the body thereto and the amounts of said acids or derivatives being 1 mg to 100 g (calculated as gamma-linolenic acid) and of said iron compounds 0.1 mg to 10 g (calculated as iron) or submultiples of said amounts convenient for daily administration thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.